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ABSTRACT-Various attempts were made to assess the role of 
the mononuclear phagocyte system in tumor resistance of rats in 
vivo. The growth of sc inoculated, weakly immunogenic, carcino-
gen-induced, syngeneic tumor cells was modestly reduced by ip 
injection and, more impressively, by local injection of peptone-
induced, activated, nonimmune macrophages. A single iv injec-
tion of silica particles or carrageenan on the day of sc tumor cell 
inoculation greatly enhanced tumor growth. When these agents 
had been given a few days before or after tumor cell inoculation, 
the tumor-promoting efficiency was distinctly diminished or even 
cancelled. The enhancing effects of silica and carrageenan on 
tumor growth were nullified by the macrophage-stabilizing agent, 
poly-2-vinylpyridine N-oxide. To assess the in vivo consequences 
of silica administration, various cellular, biochemical, and func-
tional macrophage parameters were determined at different in-
tervals. Results indicated the complexity of events elicited after 
the mononuclear phagocyte system was damaged, which made 
the interpretation of such results difficult.-J Natl Cancer Inst 57: 
1355-1361,1976. 
Many in vitro studies indicate that, in addition to the 
basic role that is assigned to lymphocytes (in tumor 
resistance), macrophages activated by specific or non-
specific means also contribute to tumor resistance (1). 
Since presently no direct or effective way exists of de-
pleting the host of macrophages, their function in tu-
mor resistance in vivo remains obscure. However, con-
siderable evidence, admittedly indirect, implies such a 
capacity for the macrophage (2). For example, in the 
Nippostrongylus brasiliensis-infected rat, tumor growth 
can either be suppressed or enhanced, depending on 
the timing of inoculation of tumor cells in relation to the 
parasite infection (3). In this (4) and other in vivo model 
systems (5, 6), suppression of tumor growth seems at-
tributable to AM, and enhancement of tumor growth 
seems due to a macrophage-inactivating factor arising 
after a nematode infection (7). Moreover, the use of 
adjuvants of microbial derivation such as BCG, Coryne-
bacterium parvum, or Listeria monocytogenes has been con-
siderably expanded, and recent evidence attests to in-
tralesional injection of the adjuvant being particularly 
effective in producing regression of established synge-
neic tumors (8-11). As the responsiveness of tumors to 
these adjuvants does not parallel their immunogenicity, 
this effect is now considered more likely to reflect the 
extent to which tumors are infiltrated by macrophages. 
Still other observations imply an inverse relationship 
between the macrophage content of tumors and tumor 
regression (12) or metastases (13). Despite these distinc-
tive approaches and the expanding magnitude of the 
effort, no convincing evidence exists that macrophages 
are directly involved in tumor resistance. 
The function of macrophages in tumor resistance is 
explored further in the present study. Various meas-
ures known to diminish the functional capacities of mac-
rophages in vitro were studied for their effect on in vivo 
tumor growth; these treatments led to markedly en-
hanced tumor growth. 
MATERIALS AND METHODS 
Animals.-Inbred female DA rats, 170-210 g, were 
used. They were maintained under conventional condi-
tions. 
In vivo experiments with tumors.-DMBA- and MCA-
induced tumors were obtained and passaged in vivo and 
maintained in tissue cultures as described in (14, 15). 
The tumor cell cultures were incubated for 2-4 days at 
37° C on mycoplasma agar and checked regularly for 
absence of mycoplasma contamination. 
Preparation of tumor cell suspensions.-The sc inocula-
tion of 2x 106 tumor cells usually leads to a localized, 
excisable subcutaneous tumor within 10-16 days. After 
necrotic parts of the tumor had been removed, the 
tissue was minced with scissors and pressed through 
nylon tissue (Schweizer Beuteltuch N ybolt; 120-125, 
ASTM) into culture medium; cell viability was assessed 
with 2% trypan blue. The number of tumor cells inocu-
lated refers to cells capable of excluding the dye (60-
70% of total cells). 
In vitro experiments with tumors.-For the assessment of 
cytostatic and cytocidal macrophage capacities, DMBA-
induced DA rat tumor cells and RPMI 7932 human 
melanoma cells that were not contaminated with myco-
plasma were used as target cells in vitro under the 
conditions described in (15, 16). 
Preparation of macrophages.-Macrophage monolayers 
were prepared as described in (14). Peritoneal cells from 
untreated controls (RM) or those obtained 3 days after 
ip injection of 10 ml of 10% proteose peptone (AM) were 
utilized as the source of adherent cells. In most experi-
ments, the peptone-induced peritoneal cells consisted of 
at least 95% cells with characteristics of macrophages 
[morphology, adherence, phagocytosis (15)]. For pas-
sive transfer studies, macrophages were removed from 
culture dishes with a rubber policeman, suspended in 
PBS (2 X 106 cells/ml), and injected immediately into syn-
geneic recipient rats. 
Macrophage supernatants were obtained after 24-
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hour culture of 107 macro phages in the presence of 200 
/.Lg heat-sterilized silica particles (Dorentrup Quartz 
# 12; average diameter, 5 /.L) and freed of silica by being 
centrifuged at 1O,000Xg for 30 minutes and passed 
through 0.3-/.L Millipore filters. 
Particulates for alteration of the mononuclear phagocyte 
system.-Silica particles were suspended in PBS and in-
jected as indicated. Carrageenan (Sea Kem 21; Marine 
Colloids, Inc., Springfield, N.J.) was dissolved in saline 
by being heated to 100° C for 15 minutes in a water bath; 
rats were given 5 mg iv in 0.5 ml saline. Trypan blue 
(Chroma, Stuttgart, Federal Republic of Germany) was 
dialyzed for 48 hours against glass-distilled water, lyoph-
ilized, and resuspended at a concentration of 10 mg/ml 
in PBS. In the first experiments, rats were given either 
ip or iv injections of trypan blue, 40 mg at 24 hours and 
10 mg at 3 hours before inoculation of tumor cells; then 
10 mg try pan blue was injected sc weekly. In later exper-
iments, rats were given a single sc injection of 20 mg 
trypan blue. 
Assessment of macrophage depletion.-The effect of silica 
treatments on the total population of peritoneal cells 
and on the number of macrophages was assessed at 
various intervals; 0.5 ml of the peritoneal washout con-
taining approximately 2 X 106 cells/ml was mixed with 1 
drop of 1 % neutral red, and the number of macro-
phages was determined by hemacytometer counts. At 
the same time, blood monocyte counts were assessed. 
PVNO (Polysciences, Inc., Warrington, Pa.) was in-
jected sc at a dose of 150 mg/kg dissolved in 0.5 ml 
saline. 
Assessment of macrophage functional activities. -Phagocy-
tosis was determined after macrophage monolayers had 
een incubated for 30 minutes at 37° C with 2 X 107 un-
treated versus opsonized SRBC in 2 ml medium; this 
process yielded an SRBC:macrophage ratio of approxi-
mately 20:1. After incubation, free SRBC were removed 
by intensive washing of the monolayers. The dishes 
were air dried, fixed in methanol, and stained with 
Giemsa; the cells were then counted. 
Cytostasis was measured after target cells were cul-
tured for 4 hours at a macrophage:target cell ratio of 
10: 1. The cells were exposed for 60 minutes at 37° C to 1 
/.LCi [3H]TDR/dish ([methyPH]TDR; 5 Ci/mmole; The 
Radiochemical Centre, Amersham, B uckinghamshire, 
England) as described in (14, 15). Data are reported as 
residual proliferation (percent of control). 
Cytolysis was determined on target cells that were 
prelabeled (2 X 106_107) with 0.05 /.LCi [14C]TDR (500 
/.LCi/mmole; The Radiochemical Centre) in 5 ml me-
dium for 12 hours, then thoroughly washed, and added 
to macrophage monolayers. The cells were then incu-
bated for 18 or 36 hours at 37° C, after which they were 
removed with a rubber policeman and centrifuged. 
After solubilization with hot perchloric acid, sediments 
and supernatants were enumerated separately in tolu-
ene:Triton X-100 (2:1) scintillation fluid containing 4 g 
2,5-bis(5-t-butylbenzoxazol-a-yl)-thiophane/liter (17) in 
a Tracerlab (ICN Pharmaceuticals N.V., Tracerlab In-
struments Division, 2800 Mechelen, Belgium) liquid 
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scintillator, and the percentage of 14C released was as-
sessed. 
Assessment of macrophage biochemical parameters . -The 
levels of various enzymes of peritoneal mononuclear 
phagocytes were measured at different intervals after ip 
injection of silica. Lactate dehydrogenase (EC 1.1.1.27; 
L-Iactate: NAD oxidoreductase) was assayed by determi-
nation of the rate of oxidation of reduced nicotinamide 
adenine dinucleotide at 340 nm (#15948; Biochemica 
LDH Test Combination, Boehringer, Mannheim, Fed-
eral Republic of Germany). Acid phosphatase activity 
was measured with sodium p-nitrophenyl phosphate as 
substrate (#15988; Biochemica Test Combination, 
Boehringer, Mannheim). f3-Glucuronidase (EC 3.2.131; 
f3-D-glucuronide glucuronohydrolase) activity was as-
sayed by the method of Talalay et al. (18). N-Acetyl-f3-D-
glucosaminidase was assayed by the method of Woollen 
et al. (19) with p-nitrophenyl-N-acetyl-f3-D-glucosamin-
ide (Sigma Chemical Co., St. Louis, Mo.) as substrate. 
All enzyme activities were expressed in IV and refer to 
2x 106 adherent peritoneal cells. The 6-hour incorpora-
tion of 0.15 /.LCi D-[14C]glucosamine/ml (200 /.LCi/mmole; 
The Radiochemical Centre) into acid-insoluble material 
of 2 X 106 adherent peritoneal cells was also determined 
(20). 
RESULTS 
Influence of Passive Transfer of Macrophages on Tumor Growth 
One way of assessing the possible role of macrophages 
in tumor growth in vivo is to supplement the host's own 
macrophage reserve by passive transfer of AM and as-
certain the effect on an sc inoculum of weakly immuno-
genic carcinogen-induced tumor cells (tables 1,2). Injec-
tion of peptone-induced AM, even at a site away from 
that of tumor cell inoculation, consistently, but mod-
estly, diminished tumor growth (table 1). The reduction 
of tumor growth was more pronounced when tumor 
cells were first admixed with a majority of AM and then 
immediately inoculated (group 2 in table 2). 
Effects of a Single Injection of Silica or Carrageenan on Host 
Resistance to Tumors 
Silica treatment markedly enhanced tumor growth, 
but the timing was crucial for this effect. Rats were given 
a single injection of 10 mg silica particles in 0.5 ml saline 
into a tail vein on days -10, -5, -3,0, or +3 of sc tumor 
cell inoculation. In several experiments, the administra-
tion of silica particles on day 0 consistently resulted in 
TABLE I.-Effect of ip inoculation of AM on growth of MeA-induced 
subcutaneous tumors a 
Mean tumor weight (g) on day 17 
Controls (0.2 ml saline ip 
on day 0) 
14.2±1.4b 
2 X 10· AM ip (in 0.2 ml saline 
on day 0) 
9.8±I.6b 
a 5 X 10· MCA-induced tumor cells were inoculated sc on day o. 
b Each value represents the mean of 15 rats. Differences in tumor 
weight between controls and rats given AM were statistically signif-
icant (P<O.OOl). 
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marked acceleration of tumor growth (table 3); the 
number of tumor takes and, even more markedly, the 
mean tumor weights were considerably increased in 
these rats. Silica treatment on day -3, and particularly 
on days +3, -5, or -10, did not interfere with host 
resistance to the tumor (table 3). Treatment of rats with 
carrageenan caused an analogous transitory diminution 
of host resistance (table 4), but only when the agent was 
given on the same day as the tumor cell inoculation. 
Effect of Repeated Injections of Silica 
In a series of experiments, rats inoculated sc with 
varying numbers of DMBA-induced syngeneic tumor 
cells were given successive injections of silica. Such con-
tinued treatment with silica particles led to an even more 
marked decrease in host resistance to the tumor (text-
fig. lA-F). In animals given larger numbers of tumor 
cells (i.e., between 103 and 5X104), the time of tumor 
appearance was markedly shortened by silica treatment. 
Thus, in controls inoculated with 104 tumor cells, it took 
24 days until the tumor was detectable in all animals; in 
the silica-treated rats, tumors had already appeared by 
day 11. As a consequence of the early appearance of 
tumors in silica-treated animals, their mean tumor 
weight, particularly during the early phase, was consist-
ently greater than that of controls. In control rats, tu-
mors regularly contained one or several necrotic foci, 
whereas the tumor tissue·of silica-treated rats was free of 
necrosis. In many experiments with control groups in-
oculated with 102 to 5 Xl 02 tumor cells, as few as 30% to a 
maximum of 70% of the rats developed tumors within 
2-3 months, whereas rats that had been given silica and 
TABLE 2.-Effect of local inoculation of AM on growth of DMBA-
induced subcutaneous tumors a 
Treatment 
Group 1: DMBA (controls) 
Group 2: AM+DMBA (10:1) 
Group 3: AM-supernatant + DMBA 
Number of 
tumor 
takes on 
day 21/to-
tal No. of 
animals 
10/10 
4/10 
10/10 
Mean tumor 
weight 
g 
8.2±1.6 
0.9±1.0 
9.7±2.1 
a 104 DMBA-induced DA rat tumor cells were inoculated sc on day 
O. In group 2, tumor cells were mixed with AM (ratio, 1:10) in vitro 
and then inoculated sc. Animals of group 3 were inoculated with 
tumor cells and supernatant from 107 AM incubated for 24 hr with 
silica. These animals were given the same amount of silica-free 
supernatant on days 1, 2, and 3. 
TABLE 3.-Abrogation of tumor resistance in DA rats by silica 
particles 
Tumor takes on Time at which silica 
was given (10 mg/rat 
iv) 
Mean tumor weight 
day 15/total No. of on day 15, g 
animals 
Controls· 
Day -10 
Day -5 
Day -3 
Day 0 
Day +3 
15/40 
7/10 
9/10 
30/30 
40/40 
13/30 
2.5±2.1 
1.9±0.9 
2.1±0.3 
6.5±5.3 
19.3±3.2 
2.5±0.7 
·10' DMBA-induced DA rat tumor cells were inoculated sc on day 
O. 
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TABLE 4.-Abrogation of tumor resistance on DA rats by carrageenan 
Time at which carra-
geenan was given (5 
mg/rat iv) 
Controls· 
Days -7, -5, -3 
Day -3 
Day 0 
Day +3 
Tumor takes on Mean tumor weight 
day 16/total No. of on day 16, g 
animals 
21/30 
13/20 
17/30 
30/30 
28/30 
5.2±3.1 
4.1±1.1 
4.6±2.1 
20.9±4.3 
5.3±3.0 
.104 DMBA-induced DA rat tumor cells were inoculated sc on day 
O. 
B 
22 
12 c 12 
10 10 
9 " 13 15 17 19 22 
12 12 
E 
10 10 
9 11 13 15 17 19 22 7 9 " 13 15 17 19 22 
TEXT-FIGURE I.-Enhancement of tumor growth by silica and its 
prevention by pretreatment with PVNO. Ordinate: Number of DA 
rats alive. Abscissa: Days after sc inoculation of DMBA-induced 
syngeneic tumor cells .• = Controls (only tumor cells); ... = silica-
treated rats; _ = PVNO+silica. PVNO was injected sc on day -I at a 
dose of 150 mg/kg; silica was injected as follows: day 0, 10 mg iv; 
days 1-3, 10 mg ip. IA) 5x 104 tumor cells sc on day 0; IB) 104 tumor 
cells sc on day 0; IC) 5xi03 tumor cells sc on day 0; ID) 103 tumor 
cells sc on day 0; IE) 5x 102 tumor cells sc on day 0; and IF) 102 
tumor cells sc on day o. 
102 tumor cells all developed tumors within 15 days 
(text-fig. lA-F). 
Effect of Carrageenan on Tumor Resistance 
A single iv injection of carrageenan the same day as 
tumor cell inoculation produced an analogous or even 
more pronounced enhancement of tumor growth. Tu-
mors appeared earlier and for the early intervals, tumor 
weights were always higher than those in tumor-bearing 
controls (not shown). On the other hand, treatment of 
rats with silica or carrageenan did not visibly affect the 
growth characteristics of the tumor; i.e., there was no 
J NATL CANCER INST 
1358 KELLER 
evidence for an increased inclination to metastasis in the 
phase of early localized tumor growth. Combined treat-
ment with silica and carrageenan had no cumulative 
tumor-enhancing effect (not shown). 
Effect of Trypan Blue on Tumor Resistance 
Hibbs (21) reported that trypan blue reduced tumor 
resistance in mice. However, the dosage of trypan blue 
he employed was toxic because 40-90% of the animals 
died within the first 5 days. In a typical experiment, 9 of 
20 rats given combined i~ections of trypan blue iv and 
sc survived the period of acute toxicity, and all 9 devel-
oped large tumors (mean wt, 18.9 vs. 3.3 g in controls). 
In rats given a single sc injection of 20 mg try pan blue, 
which produced generalized bluing without signs of 
acute toxicity, tumor growth was not different from that 
in controls (not shown). Thus the source or type of 
trypan blue used may also be a factor in the outcome. 
Prevention of Silica Effects by the Macrophage Stabilizer PVNO 
PVNO, a potent macrophage-stabilizing agent, can 
diminish the fibrogenic and other in vivo effects of silica 
in animals (22-26). Therefore, the effect of PVNO pre-
treatment on the suppressive effects of silica arul carra-
geenan on tumor resistance was examined. A single sc 
injection of PVNO on day -1 essentially nullified the 
tumor-enhancing effects of repeated administration of 
silica (text-fig. lA-F). Abrogation of tumor resistance by 
carrageenan was also largely reversed by PVNO pre-
treatment of rats (not shown). 
Effect of Silica on Peritoneal Macrophages and Blood Monocyte 
Counts in Normal Rats 
To ascertain whether silica administration affected 
the total number of cells, and particularly the adherent 
mononuclear phagocytes present in peritoneal wash-
outs, cell populations were examined at varying inter-
vals after a single iv or ip injection of 10 mg silicalrat. 
Eight and 24 hours after local injection of silica particles, 
counts of total cells and peritoneal macrophages were 
increased rather than diminished (table 5); the counts 
then returned slowly to control levels. After ip adminis-
tration of quartz, large phagolysosomes indicative of the 
ingestion of silica particles were regularly found in the 
cytoplasm of mononuclear phagocytes. The local in-
flammatory reaction to silica given ip was prevented by 
an sc injection of PVNO on the preceding day; this 
indicated that PVNO acted as a macrophage stabilizer in 
the present system. The injection of silica particles iv 
which produced no or only minor changes in the early 
phase was followed by a significant increase in the num-
ber of circulating monocytes that became evident after 
3-4 days and that generally lasted for several days. On 
the other hand, silica given iv was not immediately 
followed by significant alterations in the peritoneal leu-
kocyte population (table 5). Later on, the number of 
total peritoneal cells was generally slightly decreased. 
Effects of Silica on Cytostatic and Cytocidal Capacities of Macro-
phages 
Since the enumeration of blood monocytes and peri-
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toneal macrophages can reflect only one aspect of silica 
administration, functional parameters such as phagocy-
tosis and cytostatic and cytocidal capacity were also ex-
amined. These experiments showed that, after ip injec-
tion of 10 mg silica, phagocytosis of opsonized SRBC by 
adherent peritoneal cells was distinctly depressed for at 
least 4 days (not shown). Alterations in cytostatic and 
cytocidal peritoneal macrophage capacities after ip inoc-
ulation of silica are presented in tables 6 and 7. The data 
show that these distinctive capabilities are only weakly 
developed in untreated rats but markedly stimulated 
after local administration of peptone. However, in the 
early phase after local injection of silica particles, the 
cytocidal capacity of adherent peritoneal cells was even 
lower than that in untreated controls, i.e., for all practi-
cal purposes, absent. However, after 2-3 days, the cyto-
static and cytocidal capacities of peritoneal cells devel-
oped and reached a degree comparable to that in pep-
tone-treated rats. Even after 10-15 days of ip injection of 
silica, the cytostatic and destructive abilities of macro-
phages were markedly stimulated (not shown). 
TABLE 5.-Effect of systemic and local administration of silica 
particles on peritoneal cell populations (xl 06) a 
Time after 
Silica, 10 mg ipb Silica, 10 mg iv b 
silica injec-
Macro- Macro-tion, hr Total cells 
phages Total cells phages 
8 41.0±16c 19.9±9.3c 19.5±6.1 11.1±2.0 
24 30.3±12c 13.7±5.9c 16.3±4.3 8.2±3.0 
48 14.8±6.1 6.1±3.0 18.6±6.6 9.9±2.2 
72 17.3±9.6 6.8±3.5 17.5±7.2 9.2±3.4 
96 11.4±5.0 4.5±2.5 14.8±3.4 7.8±2.6 
a In controls, counts were 14.3±5.7 for total cells and 6. 7±2. 7 for 
macrophages. 
b Each value represents the mean of at least 20 determinations. 
CSignificantly different from controls (P<O.OOI). 
TABLE 6. -Effect of local administration of silica particles on 
macrophage cytostatic and cytocidal capacities a 
Incorporation of Release of [3H1TDR, % of [14C1TDRb, % 
Adherent peritoneal control 
cells sampled at various 
times after 10 mg ip sil- Target Target 
ica injection, hr 
RPM~ DMBA RPMI DMBA 
7932 7932 
8 73±22 76±33 6±5 3±4c 
24 53±23c 53±46 16±6 15±8 
48 44±21 c 46±40c 22±8c 23±11 C 
72 55±27 26± 13 C 27±5c 29±8c 
96 47±6 C 14±10c 26±2c 27±2c 
Adherent peritoneal 74±22 73±20 10±7 10±9 
cells from untreated 
controls (RM) 
Peptone-induced 45±17C 20±16 c 19±9c 27±12c 
adherent peritoneal 
cells (AM) 
a The ratio of effectors (2 x 106) to targets (2 x 105) was 10:1. Each 
value represents the mean of at least 20 determinations, each per-
formed in triplicate. 
b Interaction was for 18 hr. 
c These values were significantly different from controls 
(P<O.OOI). 
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TABLE 7.-Effect of local administration of silica particles on biochemical macrophage parameters a 
Incorporation Percent 
Adherent peritoneal cells sampled at Lactate de- Acid phos- f:l-Glucuron- N-Acetyl-f:l- of 
Incorpora- release of 
various times after 10 mg ip silica hydrogenase phatase idase glucosamini- [
14Clglucosa- tion of [14C1TDR 
injection, hr dase mine, counts [3HJTDRb within 18 
per minute hrb 
8 47±12c O.5±O.1 c OA±O.2c 1.4±O.2c 202±128c 88±32 3±3 
24 89±20 1.3±O.1 O.6±O.2c 2.8±O.3c 655±234 32±10c 10±3c 
48 64±27 2.0±0.9 0.5±0.2c 2.9±0.8c 654±195 38±21 c 13±8c 
Adherent peritoneal cells from 74±1O 1.6±OA 1.0±0.1 4A±1 496±338 69±14 5±2 
untreated controls (RM) 
Peptone-induced AM 148±29c 6.6±2.0c 2.2±0.6 1l.6±3 1,160±230 24±4 22±9 
a 2 X 106 adherent peritoneal cells were used. Each value represents the mean of at least 15 determinations performed in triplicate. Enzyme 
activities were expressed in IU. 
b RPMI 7932 (2x 10' cells) was used as a target; ratio of AM to targets was 10:1. Incorporation of [3H1TDR is always given in percentage of 
controls. Controls were target cells cultured in the absence of macrophages. Release of [14CJTDR within 18 hr represents the experimental 
release [spontaneous release from prelabeled targets alone (= controls) has been deductedJ. 
C Significantly different from controls. 
Effects of Silica on Biochemical Capacities of Macrophages 
The changes in biochemical parameters of peritoneal 
macrophages occurring at various intervals after ip ad-
ministration of 10 mg silica are presented in table 7. In 
the early phase after silica administration, every exam-
ined parameter was ckarly diminished; however, most 
had returned to normal within 24-48 hours. At these 
later intervals, cytostatic and cytolytic effects were again 
enhanced. The data indicate that the biochemical and 
functional activities of macro phages are differently af-
fected by silica; some remain impaired for a prolonged 
period whereas others, after a brief initial decrease, 
soon reach values distinctly higher than those in resting 
controls (table 7). 
Effect of Macrophage Supernatants on Tumor Growth 
The present observations of a marked transitory de-
crease in tumor resistance in vivo after injection of 
various agents such as silica, carrageenan, and possibly 
try pan blue-all considered to interfere primarily with 
the mononuclear phagocyte system-could be explained 
in two different ways. First, macrophages that were 
damaged, functionally eliminated, or inhibited by these 
agents were no longer available. for interaction with 
targets. Second, macrophage contents released by such 
agents might promote tumor growth. To assess the 
second possibility, silica-free supernatants from AM cul-
tured for 24 hours in the presence of silica were repeat-
edly administered into the tumor site. In most experi-
ments, such macrophage supernatants had weak 
growth-promoting effects (table 2). However, in two 
experiments in which the number of administered tu-
mor cells was especially low, macrophage supernatants 
markedly increased the number of tumor takes (table 8). 
DISCUSSION 
Mononuclear phagocytes activated by specific or non-
specific means acquire the capacity to interact with many 
targets in vitro in various ways (l, 27); however, the in 
vivo implications of these interactions are still a matter 
of conjecture. The present work which shows that pas-
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TABLE 8.-Enhancement of tumor growth by macrophage 
supernatants a 
Treatment 
None (control) 
Tumor cells mixed with AM (1:10) 
Macrophage supernatants. 
Tumor takes on 
day 30/total No. of 
animals 
2/16 
1/16 
12/16 
a 102 tumor cells were inoculated sc on day O. 
b 1 ml supernatant from 107 AM cultivated for 24 hr in the presence 
of 200 p.g silica was mixed with tumor cells and injected sc on day O. 
An additional 1 ml supernatant was injected each time into the 
tumor site 1, 2, and 3 days later. 
sively administered AM (ip, table 1, or sc with tumor 
cells, table 2) inhibit tumor growth also indicates an 
antitumor effect of AM. However, direct evidence has 
not yet been presented for macrophages as effectors of 
tumor resistance in vivo. 
Since the host cannot be depleted of macrophages, it 
was necessary to resort to less decisive alternatives. 
Among these, an especially compelling alternative de-
rives from the extraordinary selective susceptibility of 
macrophages in vitro to the cytotoxicity of silica particles 
(28, 29). Then, also, in vivo administration of silica is 
known to elicit major alterations in host resistance, e.g., 
prolonged survival of skin allografts (26,30), abrogation 
of resistance to bone marrow grafts (25), suppression of 
established delayed hypersensitivity reactions (31), and 
depression of resistance to herpes simplex virus (32, 33) 
and yellow fever virus in mice (34). Moreover, silica 
pretreatment interferes with the establishment of active 
(30,35,36) and adoptive (37) antitumor immunity and 
actually induces lymphomatous tumors in Wistar rats 
(38). Despite the lack of knowledge of the character of 
the in vivo effects elicited by silica, these findings have 
been interpreted as a reflection of macrophage deple-
tion. 5 
5 Since the completion of the present work, Levy and Wheelock 
(39) reported on the immune and nonimmune functions altered by 
silica given iv. Their data show that, among various effects, depression 
of clearance of colloidal carbon and in vitro phagocytic activity for at 
least 3 days is the most uniform change; silica had no direct depressive 
effect on cells other than macro phages. 
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Carrageenan, a high-molecular-weight sulfated poly-
galactose obtained from marine plants, affects various 
biologic systems such as blood coagulation (40, 41) and 
the complement system (42, 43). In addition, carra-
geenan is toxic for macrophages in vitro (29, 44) and 
leads to inhibition of delayed hypersensitivity reactions 
(31) and suppression of primary antibody response and 
tolerance induction in vivo (45, 46). Trypan blue, an 
inhibitor of lysosomal enzyme activity (47), is readily 
taken up into secondary lysosomes but is not ingested by 
viable lymphocytes, neutrophils, basophils, or eosino-
phils (48, 49). Accordingly, this dye appears to be an-
other useful experimental tool for the evaluation of the 
role of the macrophage in vivo (10). Apart from these 
agents, antimacrophage sera have repeatedly been 
shown to impair macrophage function both locally and 
systemically (32, 50). These observations created some 
optimism that agents such as silica, carrageenan, and 
trypan blue might provide the means for effecting a 
transient depletion-or at least a functional blocking-
of the mononuclear phagocyte system in vivo. 
The present study has shown, however, that such 
expectations were too high. Although silica does affect 
resistance to syngeneic tumors, these changes are not to 
be construed as sim pie or direct with regard to macro-
phages. Thus data such as those summarized in table 3 
demonstrate that a single iv injection of silica particles 
on the day of tumor cell inoculation largely abrogates 
resistance of DA rats to a syngeneic DMBA-induced, 
weakly immunogenic tumor. This decrease in host re-
sistance was especially conspicuous in rats inoculated 
with 102 or 5x 102 tumor cells (text-fig. 1). However, 
silica treatment was marginally effective on days -3 or 
+3 and was noneffective on days -5 or -10 (table 3);'the 
duration of the effect is thus sharply circumscribed. The 
efficacy of a single injection of carrageenan in abrogat-
ing tumor resistance was similarly pronounced and just 
as restricted to the day of tumor cell inoculation (table 
4). Trypan blue, however, was without such tumor-
enhancing effect. Although the underlying processes 
are not understood, it is noteworthy that large tumors 
excised from silica-treated animals seldom showed ne-
crosis whereas tumors from controls always contained 
one or several necrotic foci. 
As silica and carrageenan effectively promoted the 
growth of a syngeneic tumor of low immunogenicity, a 
depletion of host macro phages seemed the most direct 
mechanism by which these in vivo effects were achieved. 
However, cell counts (table 5) failed to reveal a decrease 
in the number of mononuclear phagocytes consistent 
with the observed changes in host resistance. On the 
other hand, all functional and biochemical parameters 
of the examined macrophages were distinctly dimin-
ished in the early phase after silica but often signifi-
cantly enhanced at later intervals (table 6). 
In principle, the present findings of a marked en-
hancement of tumor growth by silica and carrageenan 
could involve two essentially opposite mechanisms. The 
more obvious interpretation is that the brief period of 
clearly diminished macrophage function makes for suc-
cessful tumor implantation and initiation of progressive 
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tumor growth. However, an alternative explanation 
could be that tumor growth is simply enhanced by some 
trophic growth-promoting agent released from macro-
phages damaged by silica. Some support for this view is 
provided by the finding that macrophages and their 
culture supernatants do indeed exhibit growth-promot-
ing activity in vitro (14,27,51-53). Preliminary findings 
indicate that supernatants from silica-treated macro-
phages are potent inducers of enhanced proliferation of 
tumor cells. These two opposing interpretations are 
each reasonably consistent with most of the present 
findings. For example, the reversal of the tumor-en-
hancing effect exerted by silica and carrageenan by the 
lysosome stabilizer PVNO, a compound that effectively 
reduces or prevents the toxic, fibrogenic, and immuno-
suppressive effects of silica (22, 23,25,26,29,54), would 
be consistent with either mechanism. 
It seems reasonable that the well-documented toxicity 
in vitro of silica for macrophages is probably limited to 
the very early phases of its administration in vivo; 
quickly thereafter, the components released from dam-
aged macrophages induce an inflammatory reaction 
that gives rise to a cascade of cellular and biochemical 
consequences. The functional decline in macrophages 
observed early after the administration of silica particles 
is followed by rapid regeneration, or even a considera-
ble stimulation of important macrophage activities such 
as cytostatic and cytolytic capacities. The macrophage 
reserves of the host seem highly inexhaustible, and the 
paradoxical possibility should be considered that some 
constituents released by damaged macrophages may ac-
tually trigger or signal their migration from the bone 
marrow or perhaps even their local proliferation (55, 
56). It is thus evident that extrapolation from the in vitro 
findings on silica cytotoxicity is misleading. Accord-
ingly, this approach is unsuitable for appraising the 
contribution of macro phages to host resistance. 
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